|
1
|
Brodeur GM: Neuroblastoma: biological
insights into a clinical enigma. Nat Rev Cancer. 3:203–216. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ciccarone V, Spengler BA, Meyers MB,
Biedler JL and Ross RA: Phenotypic diversification in human
neuroblastoma cells: expression of distinct neural crest lineages.
Cancer Res. 49:219–225. 1989.PubMed/NCBI
|
|
3
|
Reya T, Morrison SJ, Clarke MF and
Weissman IL: Stem cells, cancer, and cancer stem cells. Nature.
414:105–111. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Clarke MF, Dick JE, Dirks PB, et al:
Cancer stem cells - perspectives on current status and future
directions: AACR Workshop on Cancer Stem cells. Cancer Res.
66:9339–9344. 2006. View Article : Google Scholar
|
|
5
|
Smas CM and Sul HS: Pref-1, a protein
containing EGF-like repeats, inhibits adipocyte differentiation.
Cell. 73:725–734. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Moore KA, Pytowski B, Witte L, Hicklin D
and Lemischka IR: Hematopoietic activity of a stromal cell
transmembrane protein containing epidermal growth factor-like
repeat motifs. Proc Natl Acad Sci USA. 94:4011–4016. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hunter T: Protein kinases and
phosphatases: the yin and yang of protein phosphorylation and
signaling. Cell. 80:225–236. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Berwick DC, Calissano M, Corness JD, Cook
SJ and Latchman DS: Regulation of Brn-3a N-terminal transcriptional
activity by MEK1/2-ERK1/2 signalling in neural differentiation.
Brain Res. 1256:8–18. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ruiz-Hidalgo MJ, Gubina E, Tull L,
Baladron V and Laborda J: dlk modulates mitogen-activated protein
kinase signaling to allow or prevent differentiation. Exp Cell Res.
274:178–188. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Burdon T, Smith A and Savatier P:
Signalling, cell cycle and pluripotency in embryonic stem cells.
Trends Cell Biol. 12:432–438. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mayne ST: Beta-carotene, carotenoids, and
disease prevention in humans. FASEB J. 10:690–701. 1996.PubMed/NCBI
|
|
12
|
Comstock GW, Alberg AJ, Huang HY, et al:
The risk of developing lung cancer associated with antioxidants in
the blood: ascorbic acids, carotenoids, α-tocopherol, selenium, and
total peroxyl radical absorbing capacity. Am J Epidemiol.
168:831–840. 2008.PubMed/NCBI
|
|
13
|
Liu C, Russell RM and Wang XD: Low dose
β-carotene supplementation of ferrets attenuates smoke-induced lung
phosphorylation of JNK, p38 MAPK, and p53 proteins. J Nutr.
134:2705–2710. 2004.
|
|
14
|
Burton GW and Ingold KU: beta-Carotene: an
unusual type of lipid antioxidant. Science. 224:569–573. 1984.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tighe AP and Gudas LJ: Retinoic acid
inhibits leukemia inhibitory factor signaling pathways in mouse
embryonic stem cells. J Cell Physiol. 198:223–229. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fenaux P, Chevret S, Guerci A, et al:
Long-term follow-up confirms the benefit of all-trans
retinoic acid in acute promyelocytic leukemia. European APL group.
Leukemia. 14:1371–1377. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kakarala M, Brenner DE, Korkaya H, et al:
Targeting breast stem cells with the cancer preventive compounds
curcumin and piperine. Breast Cancer Res Treat. 122:777–785. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Corrao S, Scaglione R, Arnone S and Licata
G: Left ventricular diastolic filling alterations in subjects with
mitral valve prolapse: a Doppler echocardiographic study. Eur Heart
J. 14:369–372. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Denizot F and Lang R: Rapid colorimetric
assay for cell growth and survival. Modifications to the
tetrazolium dye procedure giving improved sensitivity and
reliability. J Immunol Methods. 89:271–277. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kim Y, Lin Q, Zelterman D and Yun Z:
Hypoxia-regulated delta-like 1 homologue enhances cancer cell
stemness and tumorigenicity. Cancer Res. 69:9271–9280. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Folkman J and Moscona A: Role of cell
shape in growth control. Nature. 273:345–349. 1978. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lin Q, Lee YJ and Yun Z: Differentiation
arrest by hypoxia. J Biol Chem. 281:30678–30683. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gross MD, Bishop TD, Belcher JD and Jacobs
DR Jr: Induction of HL-60 cell differentiation by carotenoids. Nutr
Cancer. 27:169–173. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Noguchi S, Sumida T, Ogawa H, Tada M and
Takahata K: Effects of oxygenated carotenoid beta-cryptoxanthin on
morphological differentiation and apoptosis in Neuro2a
neuroblastoma cells. Biosci Biotechnol Biochem. 67:2467–2469. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Prasad KN, Carvalho E, Kentroti S, et al:
Production of terminally differentiated neuroblastoma cells in
culture. Restor Neurol Neurosci. 7:13–19. 1994.PubMed/NCBI
|
|
26
|
Favata MF, Horiuchi KY, Manos EJ, et al:
Identification of a novel inhibitor of mitogen-activated protein
kinase kinase. J Biol Chem. 273:18623–18632. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Dang ZC and Lowik CW: Differential effects
of PD98059 and U0126 on osteogenesis and adipogenesis. J Cell
Biochem. 92:525–533. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kim Y: Effect of retinoic acid and
delta-like 1 homologue (DLK1) on differentiation in neuroblastoma.
Nutr Res Pract. 4:276–282. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang XD and Krinsky NI: The bioconversion
of beta-carotene into retinoids. Subcell Biochem. 30:159–180. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Floridon C, Jensen CH, Thorsen P, et al:
Does fetal antigen 1 (FA1) identify cells with regenerative,
endocrine and neuroendocrine potentials? A study of FA1 in
embryonic, fetal, and placental tissue and in maternal circulation.
Differentiation. 66:49–59. 2000. View Article : Google Scholar
|
|
31
|
Tornehave D, Jensen CH, Teisner B and
Larsson LI: FA1 immunoreactivity in endocrine tumours and during
development of the human fetal pancreas; negative correlation with
glucagon expression. Histochem Cell Biol. 106:535–542. 1996.
View Article : Google Scholar
|
|
32
|
Sakajiri S, O’Kelly J, Yin D, et al: Dlk1
in normal and abnormal hematopoiesis. Leukemia. 19:1404–1410. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yin D, Xie D, Sakajiri S, et al: DLK1:
increased expression in gliomas and associated with oncogenic
activities. Oncogene. 25:1852–1861. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ben-Porath I, Thomson MW, Carey VJ, et al:
An embryonic stem cell-like gene expression signature in poorly
differentiated aggressive human tumors. Nat Genet. 40:499–507.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
35
|
Phillips HS, Kharbanda S, Chen R, et al:
Molecular subclasses of high-grade glioma predict prognosis,
delineate a pattern of disease progression, and resemble stages in
neurogenesis. Cancer Cell. 9:157–173. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Quasthoff S and Hartung HP:
Chemotherapy-induced peripheral neuropathy. J Neurol. 249:9–17.
2002. View Article : Google Scholar
|
|
37
|
Huang H, Zhu L, Reid BR, Drobny GP and
Hopkins PB: Solution structure of a cisplatin-induced DNA
interstrand cross-link. Science. 270:1842–1845. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Donzelli E, Carfi M, Miloso M, et al:
Neurotoxicity of platinum compounds: comparison of the effects of
cisplatin and oxaliplatin on the human neuroblastoma cell line
SH-SY5Y. J Neurooncol. 67:65–73. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Bruce AC: Cancer: Principles and practice
of oncology. Anticancer Drugs. DeVita VT, Lawrence TS and Rosenberg
SA: JB Lippincot Company; Washington: pp. 325–340. 1993
|
|
40
|
Teicher BA, Schwartz JL, Holden SA, Ara G
and Northey D: In vivo modulation of several anticancer agents by
beta-carotene. Cancer Chemother Pharmacol. 34:235–241. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Prasad KN, Hernandez C, Edwards-Prasad J,
Nelson J, Borus T and Robinson WA: Modification of the effect of
tamoxifen, cis-platin, DTIC, and interferon-α 2b on human
melanoma cells in culture by a mixture of vitamins. Nutr Cancer.
22:233–245. 1994.PubMed/NCBI
|
